Eisai

4523.TSE

31.56 USD

-0.92

-2.83%

Overview

Last close

31.56 usd

Market cap

8.90B usd

52 week high

36.74 usd

52 week low

24.09 usd

Target price

31.69 usd

Valuation

P/E

28.8927

Forward P/E

32.6797

Price/Sales

1.7611

Price/Book Value

1.6334

Enterprise Value

8.56B usd

EV/Revenue

1.6953

EV/EBITDA

12.3896

Key financials

Revenue TTM

5.08B usd

Gross Profit TTM

3.95B usd

EBITDA TTM

559.03M usd

Earnings per Share

1.1 usd

Dividend

1 usd

Total assets

9.49B usd

Net debt

-564.15M usd

About

Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in India. It also offers prescription medicines. In addition, the company focuses on neurology and oncology and therapeutic areas. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.